Table 5 Resistance degree of Gram-positive bacterial isolates to each antibiotic used
Antibiotic | S. aurus | CON Staphylococcus | Streptococcus spp. |
|---|---|---|---|
Penicillins group | Â | ||
Penicillin (P 10) | 83 | 100 | 33 |
Ampicillin (AMP 10) | 83 | 83 | 33 |
Amoxicillin-clavulanic acid (AMC 30) | 50 | 33 | 0 |
Sulbactam/ampicillin (SAM 20) | 33 | 17 | 0 |
Cephalosporins group | Â | ||
Ceftazidime (CAZ 30) | 50 | 17 | 0 |
cefixime (CFM 5) | 83 | 83 | 33 |
Cefoperazone (CFP 75) | 33 | 17 | 0 |
Ceftriaxone (CRO 30) | 33 | 33 | 0 |
Cefotaxime (CTX 30) | 50 | 33 | 0 |
Cefepime (FEP 30) | 33 | 33 | 0 |
DNA synthesis Inhibitors (Fluoroquinolones) | Â | ||
Ciprofloxacin (CIP 5) | 50 | 33 | 0 |
Norfloxacin (NOR 10) | 50 | 33 | 0 |
Ofloxacin (OFX 5) | 50 | 33 | 0 |
Protein Synthesis Inhibitors | Â | ||
Amikacin (AK 30) | 0 | 0 | 33 |
Gentamicin (CN 10) | 17 | 17 | 33 |
Glycylcycline (TGC 150) | 0 | 0 | 0 |
Chloramphenicol (CL 30) | 50 | 33 | 0 |
Carbapenems group | Â | Â | Â |
Ertapenem (ETP 10) | 50 | 33 | 0 |
Meropenem (MEM 10) | 50 | 17 | 0 |
Others | Â | ||
Ceftazidime-avibactam (CZA 50) | 33 | 17 | 0 |
Ceftolozane/tazobactam (C/T) | 50 | 17 | 0 |
Cefoperazone/Sulbactam (SCF 105) | 17 | 0 | 0 |
Sulphamethoxazole/trimethoprim (SXT 25) | 50 | 33 | 33 |
piperacillin/tazobactam (TZP 110) | 17 | 17 | 0 |
Gram-positive antibiotics | Â | Â | Â |
Clindamycin (DA 2) | 33 | 50 | 0 |
Erythromycin (E 15) | 33 | 50 | 0 |
Linezolid (LZD 30) | 17 | 17 | 0 |
Oxacillin (OX 1) | 50 | 50 | 0 |